Baker Bros. Advisors LP 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Baker Bros. Advisors LP | 0 0.000% | -2,168,000 (Position Closed) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Baker Bros. Advisors LP | 2,168,000 5.100% | 2,168,000 (New Position) | Filing |